Biodesix, Inc. (BDSX)
USD 1.34
(-3.6%)
USD 1.34
(-3.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -37.1 Million USD | 28.98% |
| 2022 | -53.77 Million USD | -28.15% |
| 2021 | -35.47 Million USD | -81.43% |
| 2020 | -20.84 Million USD | 2.18% |
| 2019 | -24.92 Million USD | -26.39% |
| 2018 | -21.51 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -6.85 Million USD | 22.64% |
| 2024 Q1 | -9.63 Million USD | -77.35% |
| 2024 Q3 | -8.59 Million USD | 9.97% |
| 2023 Q2 | -9.5 Million USD | 41.85% |
| 2023 Q1 | -16.35 Million USD | -17.69% |
| 2023 FY | - USD | 28.98% |
| 2023 Q4 | -5.54 Million USD | 22.72% |
| 2023 Q3 | -7.17 Million USD | 24.59% |
| 2022 Q2 | -10.18 Million USD | 22.76% |
| 2022 FY | - USD | -28.15% |
| 2022 Q4 | -13.89 Million USD | -55.34% |
| 2022 Q1 | -13.18 Million USD | -12.76% |
| 2022 Q3 | -8.94 Million USD | 12.14% |
| 2021 Q3 | -12.29 Million USD | -34.02% |
| 2021 Q1 | -3.85 Million USD | -40.21% |
| 2021 FY | - USD | -81.43% |
| 2021 Q4 | -11.68 Million USD | 4.9% |
| 2021 Q2 | -9.17 Million USD | -138.02% |
| 2020 Q2 | -5.73 Million USD | 14.02% |
| 2020 FY | - USD | 2.18% |
| 2020 Q4 | -2.74 Million USD | 49.15% |
| 2020 Q3 | -5.4 Million USD | 5.69% |
| 2020 Q1 | -6.66 Million USD | -146.36% |
| 2019 Q2 | -5.24 Million USD | 0.0% |
| 2019 FY | - USD | -26.39% |
| 2019 Q4 | -2.7 Million USD | 67.0% |
| 2019 Q3 | -8.19 Million USD | -56.21% |
| 2019 Q1 | -5.24 Million USD | 0.0% |
| 2018 Q1 | -5.37 Million USD | 0.0% |
| 2018 Q2 | -5.37 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 82.63% |
| Prenetics Global Limited | -47.89 Million USD | 22.534% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -2099.348% |
| CareDx, Inc | -89.65 Million USD | 58.617% |
| Exact Sciences Corporation | 41.87 Million USD | 188.602% |
| Exagen Inc. | -19.15 Million USD | -93.719% |
| Inotiv, Inc. | -26.5 Million USD | -39.98% |
| Guardant Health, Inc. | -433.3 Million USD | 91.437% |
| BioNexus Gene Lab Corp. | -2.48 Million USD | -1392.982% |
| Precipio, Inc. | -4.31 Million USD | -759.264% |
| iSpecimen Inc. | -9.1 Million USD | -307.559% |
| Natera, Inc. | -383.27 Million USD | 90.32% |
| Aspira Women's Health Inc. | -16.49 Million USD | -124.989% |
| Standard BioTools Inc. | -54.45 Million USD | 31.867% |
| 23andMe Holding Co. | -291.87 Million USD | 87.288% |
| Castle Biosciences, Inc. | -45.02 Million USD | 17.593% |
| Personalis, Inc. | -96.8 Million USD | 61.673% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 68.44% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | -286.851% |
| OpGen, Inc. | -29.51 Million USD | -25.726% |
| T2 Biosystems, Inc. | -43.87 Million USD | 15.435% |
| Myriad Genetics, Inc. | -67.8 Million USD | 45.276% |
| ICON Public Limited Company | 1.63 Billion USD | 102.274% |
| NeoGenomics, Inc. | -17.6 Million USD | -110.729% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -2099.348% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 103.047% |
| RadNet, Inc. | 292.78 Million USD | 112.672% |
| MDxHealth SA | -30.46 Million USD | -21.777% |
| Psychemedics Corporation | -251 Thousand USD | -14682.072% |
| Illumina, Inc. | -608 Million USD | 93.898% |
| Check-Cap Ltd. | -17.64 Million USD | -110.227% |
| Twist Bioscience Corporation | -176.7 Million USD | 79.003% |
| DarioHealth Corp. | -53.49 Million USD | 30.641% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 20.298% |
| Sera Prognostics, Inc. | -35.28 Million USD | -5.146% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | -279.19% |
| OPKO Health, Inc. | -65.51 Million USD | 43.368% |
| Medpace Holdings, Inc. | 363.15 Million USD | 110.217% |
| Neogen Corporation | 182.59 Million USD | 120.32% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | -321.113% |
| Prenetics Global Limited | -47.89 Million USD | 22.534% |
| Mainz Biomed B.V. | -25.01 Million USD | -48.346% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -386.322% |
| Trinity Biotech plc | -24.09 Million USD | -53.967% |
| Neuronetics, Inc. | -22.75 Million USD | -63.026% |
| Sotera Health Company | 514.14 Million USD | 107.216% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | -386.322% |